10 pending office actions • 8 art units • 10 examiners • 0 of 10 (0%) have an AI response strategy ready • 14 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (10%) |
| §103 only | 5 (50%) |
| Double-patenting only | 1 (10%) |
| Multi-statute (no §101) | 3 (30%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WINAKUR, ERIC FRANK | 1 | 79.2% | +13.8% |
| HAMA, JOANNE | 1 | 25.1% | +38.8% |
| LUK, EMMANUEL S | 1 | 71.3% | +26.4% |
| KWON, YONG SOK | 1 | 24.6% | +42.7% |
| SISON, CHRISTINE ANDREA PAN | 1 | 31.9% | +47.3% |
| ALLEN, SARAH ELIZABETH | 1 | 60.9% | +45.0% |
| RAUBENSTRAW, TYLER ALLEN | 1 | 71.1% | +30.7% |
| PARK, HAEJIN S | 1 | 55.1% | +38.5% |
| COOK, LISA V | 1 | 67.3% | +10.0% |
| RAMADAN, OMAR | 1 | 24.2% | +59.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17471513 | METHODS FOR CARDIOVASCULAR DISEASE IN RHEUMATOID ARTHRITIS | RAMADAN, OMAR | 37d overdue |
| 18867687 | DEVICES AND METHODS FOR TRANSCUTANEOUS BILIRUBIN MEASUREMENT | WINAKUR, ERIC FRANK | — |
| 18865259 | METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING INFLAMMATORY SKIN DISORDERS | HAMA, JOANNE | — |
| 18667950 | GENERATION OF S-NITROSOACETYLCYSTEINE | KWON, YONG SOK | — |
| 18022230 | GENERATION OF NITRIC OXIDE AND DELIVERY SYSTEMS | RAUBENSTRAW, TYLER ALLEN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17765926 | MULTI-LAYERED NANOPARTICLE COATED SUBSTRATES FOR DRUG DELIVERY | PARK, HAEJIN S | 162d overdue |
| 18337705 | SELECTIVE STIMULATION OF GROUPS OF NEURAL ELEMENTS WITHIN A REGION OF THE BRAIN | SISON, CHRISTINE ANDREA PAN | 60d overdue |
| 17471513 | METHODS FOR CARDIOVASCULAR DISEASE IN RHEUMATOID ARTHRITIS | RAMADAN, OMAR | 37d overdue |
| 18906524 | ALTERNATING FIELD ELECTRODE SYSTEM AND METHOD FOR FIBER GENERATION | LUK, EMMANUEL S | 31d overdue |
| 18315677 | PRE-CLINICAL MODIFIED RNA APPROACHES USED IN LARGE ANIMALS FOR MUSCLE AND VASCULAR REGENERATION | ALLEN, SARAH ELIZABETH | 16d overdue |
| 18867687 | DEVICES AND METHODS FOR TRANSCUTANEOUS BILIRUBIN MEASUREMENT | WINAKUR, ERIC FRANK | — |
| 18865259 | METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING INFLAMMATORY SKIN DISORDERS | HAMA, JOANNE | — |
| 18667950 | GENERATION OF S-NITROSOACETYLCYSTEINE | KWON, YONG SOK | — |
| Art Unit | Apps |
|---|---|
| 1645 | 1 |
| 1744 | 1 |
| 3796 | 1 |
| 1637 | 1 |
| 3785 | 1 |
| 1614 | 1 |
| 1642 | 1 |
| 1678 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18867687 | DEVICES AND METHODS FOR TRANSCUTANEOUS BILIRUBIN MEASUREMENT | WINAKUR, ERIC FRANK | — | §102§103§112 | Non-Final OA | — | Pending | Nov 20, 2024 |
| 18865259 | METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING INFLAMMATORY SKIN DISORDERS | HAMA, JOANNE | 1645 | §103 | Non-Final OA | — | Pending | Nov 12, 2024 |
| 18906524 | ALTERNATING FIELD ELECTRODE SYSTEM AND METHOD FOR FIBER GENERATION | LUK, EMMANUEL S | 1744 | DP | Final Rejection | 31d overdue | Pending | Oct 04, 2024 |
| 18667950 | GENERATION OF S-NITROSOACETYLCYSTEINE | KWON, YONG SOK | — | §102§103§112 | Non-Final OA | — | Pending | May 17, 2024 |
| 18337705 | SELECTIVE STIMULATION OF GROUPS OF NEURAL ELEMENTS WITHIN A REGION OF THE BRAIN | SISON, CHRISTINE ANDREA PAN | 3796 | §103 | Final Rejection | 60d overdue | Pending | Jun 20, 2023 |
| 18315677 | PRE-CLINICAL MODIFIED RNA APPROACHES USED IN LARGE ANIMALS FOR MUSCLE AND VASCULAR REGENERATION | ALLEN, SARAH ELIZABETH | 1637 | §103 | Final Rejection | 16d overdue | Pending | May 11, 2023 |
| 18022230 | GENERATION OF NITRIC OXIDE AND DELIVERY SYSTEMS | RAUBENSTRAW, TYLER ALLEN | 3785 | §103§112 | Non-Final OA | — | Pending | Feb 20, 2023 |
| 17765926 | MULTI-LAYERED NANOPARTICLE COATED SUBSTRATES FOR DRUG DELIVERY | PARK, HAEJIN S | 1614 | §103 | Final Rejection | 162d overdue | Pending | Apr 01, 2022 |
| 17479453 | METHOD FOR INCREASING CELL SUSCEPTIBILITY TO COMPLEMENT- MEDIATED LYSIS | COOK, LISA V | 1642 | §103 | Non-Final OA | — | Pending | Sep 20, 2021 |
| 17471513 | METHODS FOR CARDIOVASCULAR DISEASE IN RHEUMATOID ARTHRITIS | RAMADAN, OMAR | 1678 | §101 | Non-Final OA | 37d overdue | Pending | Sep 10, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial